Washington People: John C. Clohisy
				p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;margin-bottom:.0001pt;font-size:12.0pt;font-family:Times;}
.MsoChpDefault
{font-family:Cambria;}
@page WordSection1
{size:8.5in 11.0in;margin:1.0in 1.25in 1.0in 1.25in;}
div.WordSection1
{page:WordSection1;}
Orthopaedic surgeon John C. Clohisy, MD, came from a medical family. His father was a general surgeon, and his mother a nurse anesthetist. More than half of their 10 children followed them into the field. But even that family pedigree didn’t make a career in medicine a “slam dunk” for Clohisy because he also was interested in teaching and research. Luckily, academic medicine allows him to pursue all three. 
			
		
					
			Campus Sustainability Week at medical school offers something for everyone
				Washington University School of Medicine in St. Louis will celebrate  Campus Sustainability Week Oct. 17-21 with various speakers and  information stations around the campus.
			
		
					
			Studies examine diet’s role in prostate cancer
				The typical American diet includes nearly twice the recommended daily allowance for protein, and now a team of nutrition researchers, including Luigi Fontana, MD, PhD, and urologic surgeons at the School of Medicine, is conducting two studies to investigate a potential link between cancer and excess protein in the diet.   
			
		
					
			Preterm infants exposed to stressors in NICU display reduced brain size
				New research by Washington University School of Medicine researchers, including Terrie E. Inder, MD, shows that exposure to stressors in the neonatal intensive care unit (NICU) is associated with alterations in the brain structure and function of very preterm infants.
			
		
					
			Center for History of Medicine to open at the School of Medicine
				Washington University School of Medicine in St. Louis has opened a new Center for History of Medicine to stimulate student and faculty studies of the ways progress takes place in medicine and science. The center is on the sixth floor of Washington University’s Bernard Becker Medical Library. 
			
		
					
			Natural compound helps reverse diabetes in mice
				Researchers at Washington University School of Medicine in St. Louis have restored normal blood sugar metabolism in diabetic mice using a compound the body makes naturally. The finding suggests that it may one day be possible for people to take the compound much like a daily vitamin as a way to treat or even prevent type 2 diabetes.
			
		
					
			Wright named Jones Professor in Orthopaedic Surgery
				p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;margin-bottom:.0001pt;font-size:12.0pt;font-family:Times;}
.MsoChpDefault
{font-family:Cambria;}
@page WordSection1
{size:8.5in 11.0in;margin:1.0in 1.25in 1.0in 1.25in;}
div.WordSection1
{page:WordSection1;}
Rick W. Wright, MD, has been named the Dr. Asa C. and Mrs. Dorothy W. Jones Professor in Orthopaedic Surgery at Washington University School of Medicine in St. Louis. An author of more than 100 scientific publications, Wright joined the Washington University faculty as an instructor in 1994 and became a full professor in 2010. He is a frequently invited lecturer, nationally and internationally. 
			
		
					
			Federal funding cut leads to layoffs at WUSTL’s Genome Institute
				p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;margin-bottom:.0001pt;font-size:12.0pt;font-family:’Times New Roman’;}
.MsoChpDefault
{;}
@page WordSection1
{size:8.5in 11.0in;margin:1.0in 1.25in 1.0in 1.25in;}
div.WordSection1
{page:WordSection1;}
The university’s Genome Institute is laying off 54 employees due to a reduction in funding from the National Human Genome Research Institute for large-scale genome centers.
			
		
					
			A walk in the park
				About 1,500 School of Medicine employees took a walk in Hudlin Park Sept. 28 to kick off Tread the Med, the school’s walking campaign. More than 120 teams and nearly 1,900  employees have registered for the program, which encourages walking  10,000 steps a day.
			
		
					
			Genetic variant linked to blocked heart arteries in patients with diabetes
				Researchers have identified the first genetic variant associated with severity of coronary artery disease in patients with type 2 diabetes. Though this variant is not likely the cause of more severe coronary disease, the researchers say, it implicates a gene that could be. Such a gene has promise as a future target for treating coronary artery disease in diabetic patients.
			
		
					
			View More Stories